Would you consider SBRT or more conventionally fractionated radiation for an in-field mediastinal recurrence of esophageal adenocarcinoma s/p preoperative CRT, esophagectomy, and now progressing on immunotherapy?   

How would your decision differ if the patient was not on immunotherapy or other systemic therapy? Would your thinking differ depending on the timing of the recurrence?



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Munson Medical Center
Dr. @Atkins brings up all the relevant consid...
Radiation Oncologist at Fox Chase Cancer Center
I agree with Dr. @Atkins Atkins and Dr. @Forster. ...
Radiation Oncologist at University of Nebraska Medical Center
Great discussion. I don't usually re-irradiate the...
Sign in or Register to read more